Paradigm Biopharmaceuticals Ltd.ASX: PAR

PAR reports consistent pain reduction in knee OA of patients

May 28, 2019 at 2:45 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment